Target intelligence / Profile preview

Jun proto-oncogene, AP-1 transcription factor subunit (c-Jun)

Target
c-Jun
Molecular classification
Transcription factor, Oncoprotein
01

Overview

Jun proto-oncogene, AP-1 transcription factor subunit (commonly known as c-Jun) is a protein encoded by the *JUN* gene in humans. It is a key component of the activator protein 1 (AP-1) transcription complex, typically forming heterodimers with proteins from the FOS family to regulate gene expression by binding specific DNA sequences. As one of the first discovered oncogenic transcription factors, c-Jun plays critical roles in controlling cell proliferation, apoptosis, differentiation, response to extracellular signals (such as growth factors and stress), and axon regeneration after nerve injury. The *JUN* gene is intronless and located at chromosome region 1p32-p31—a locus frequently altered in various malignancies including neuroblastoma. Overexpression or amplification of JUN has been observed in several aggressive cancers. While no direct small-molecule inhibitors are clinically approved for this target itself based on current data provided here, modulation often occurs through inhibition of upstream kinases like JNK that phosphorylate and activate c-Jun.

Other names
c-JunJUNAP-1 transcription factor subunitTranscription factor Junp39
02

Mechanism of action

Not specified for direct drugs; generally involves inhibition of AP-1 activity or upstream kinases such as JNK that activate c-Jun.

03

Biological functions

Regulation of gene expressionCell proliferationApoptosisCellular differentiationResponse to stress and cytokinesAxon regeneration
04

Disease associations

Cancer (including vulvar squamous cell carcinoma and sarcomas)Neuroblastoma (chromosomal region involvement)Nerve injury/regeneration disorders
05

Safety considerations

Not specifically detailed in the search results. Potential concerns could include effects on normal cellular proliferation and differentiation due to broad regulatory roles.
06

Biomarkers

Overexpression of c-Jun can serve as a biomarker in certain cancers such as vulvar squamous cell carcinoma.

Beyond the preview

Go deeper on Jun proto-oncogene, AP-1 transcription factor subunit (c-Jun).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jun proto-oncogene, AP-1 transcription factor subunit (c-Jun).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call